Detail
| LncRNA Name | ASK00420 |
| Synonyms | NA |
| Region | NA Sequence |
| Ensembl | NA |
| RefSeq | NA |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✔ |
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | microarray, qPCR, RNAi, Western blot, RIP etc. |
| Sample | cervical cancer tissues, cell lines (HeLa, SiHa, CaSki) |
| Expression Pattern | down-regulated |
| Function Description | LncRNA expression was then analyzed in CC cells and normal, primary cervical epithelial cells in the same manner. The levels of TI17313, TI13831, TI10124, and TI18318 were increased in 3 cancer cell lines (HeLa, SiHa, and CaSki) when compared with normal, primary cervical epithelial cells. Expression of the 5 other lncRNAs was below the level of detection in cultured cells. |
| Pubmed ID | 25007342 |
| Year | 2014 |
| Title | Long noncoding RNA-EBIC promotes tumor cell invasion by binding to EZH2 and repressing E-cadherin in cervical cancer. |
| External Links |
| Links for ASK00420 | GenBank HGNC lncrnadb Noncode |
| Links for cervical cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.